24 HOUR WU ALLOCATION
| Research | Percent |
|---|---|
|
PEPTIDOMIMETIC CD40L BINDING |
40.23% |
|
CANCER |
36.84% |
|
ALZHEIMERS |
22.93% |
7 DAY WU ALLOCATION
| Research | Percent |
|---|---|
|
PEPTIDOMIMETIC CD40L BINDING |
46.21% |
|
ALZHEIMERS |
33.97% |
|
CANCER |
19.82% |
12 WEEK WU ALLOCATION
| Research | Percent |
|---|---|
|
PEPTIDOMIMETIC CD40L BINDING |
46.19% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATIONS |
19.25% |
|
ALZHEIMERS |
15.38% |
|
CANCER |
11.06% |
|
NIPAH VIRUS DECOY PROTEIN DYNAMICS |
4.19% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATION DYNAMICS |
1.91% |
|
NIPAH VIRUS DECOY PROTEIN DESIGN |
1.26% |
|
MEMBRANE TRANSPORT |
.76% |